Glofil-125 Injection, Solution
Product Images NDC 50914-7729

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glofil-125 (NDC 50914-7729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Iso-tex Diagnostics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label 2)

Label for Glofil-125 Sodium Iothalamate I 125 injection, solution form for intravenous use. The label states a 4 mL fill with radioactive material caution symbols. It lists storage at 2°C to 8°C and indicates manufacture by Iso-Tex Diagnostics, Inc., Friendswood, TX 77546. The active ingredient and radioactive nature are noted along with instructions to see the package insert and a barcode with NDC 50914-7729-2.*

FDA Label Image

Image Description (Table 1)

A table titled 'Principal Radiation Emission Data' listing types of radiation including Gamma-1 and various X-rays (Ka1, Ka2, Kβ1, Kβ2, Kβ3) with corresponding mean number per disintegration and mean energy in keV. The table references ICRP Publication 38 on radionuclide transformations and radiation emission intensity.*

FDA Label Image

Image Description (Table 2)

A table titled 'Radiation Attenuation by Lead Shielding' listing lead shield thicknesses in millimeters and their corresponding coefficients of attenuation. The data shows decreasing attenuation coefficients with increasing lead thickness, accompanied by a note citing Oak Ridge Associated Universities, Radiopharmaceutical Internal Dose Information Center, Oak Ridge, TN, 1989 as the source.*

FDA Label Image

Image Description (Table 3)

A physical decay chart for Iodine-125 showing the fraction remaining over a period of days up to 45 days. The chart indicates the half-life of I-125 as 60.14 days, listing the fraction remaining for each day from 0 through 45.*

FDA Label Image

Image Description (Table 4)

Data table titled 'Absorbed Radiation Doses' presenting absorbed radiation doses for 100 μCi (3.7 megabecquerels) at two bladder voiding intervals (2 hours and 4.8 hours) across various organs. Radiation exposure is listed in rads and mGy for organs including lower large intestine wall, small intestine, stomach, upper large intestine wall, kidneys, liver, ovaries, testes, urinary bladder wall, red marrow, thyroid, and total body. The data source is Oak Ridge Associated Universities, Radiopharmaceutical Internal Dose Information Center, 1988.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.